These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26908063)

  • 1. The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer.
    Aragon-Ching JB
    Asian J Androl; 2016; 18(4):592-3. PubMed ID: 26908063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PARP (poly(ADP-ribose) polymerase) family].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():71-7. PubMed ID: 23513815
    [No Abstract]   [Full Text] [Related]  

  • 4. 3. Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia.
    Pellicciari R; Camaioni E; Costantino G
    Prog Med Chem; 2004; 42():125-69. PubMed ID: 15003720
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
    Cavone L; Chiarugi A
    Trends Mol Med; 2012 Feb; 18(2):92-100. PubMed ID: 22078487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A
    Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1.
    Beneke S; Cohausz O; Malanga M; Boukamp P; Althaus F; Bürkle A
    Nucleic Acids Res; 2008 Nov; 36(19):6309-17. PubMed ID: 18835851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.
    Wang B; Qian H; Yiu SM; Sun J; Zhu G
    Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP-1 inhibition to treat cancer, ischemia, inflammation.
    Graziani G; Battaini F; Zhang J
    Pharmacol Res; 2005 Jul; 52(1):1-4. PubMed ID: 15911328
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Park CH; Chun K; Joe BY; Park JS; Kim YC; Choi JS; Ryu DK; Koh SH; Cho GW; Kim SH; Kim MH
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2250-3. PubMed ID: 20189385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP inhibitors and heart failure--translational medicine caught in the act.
    Booz GW
    Congest Heart Fail; 2007; 13(2):105-12. PubMed ID: 17392615
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.
    Kauppinen TM
    Neurochem Int; 2007 Jun; 50(7-8):954-8. PubMed ID: 17222947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
    Schreiber V; Illuzzi G; Héberlé E; Dantzer F
    Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaccharide pyrimidine nucleosides and their derivatives: a novel group of cell-penetrating inhibitors of poly(ADP-ribose) polymerase 1.
    Efremova AS; Zakharenko AL; Shram SI; Kulikova IV; Drenichev MS; Sukhanova MV; Khodyreva SN; Myasoedov NF; Lavrik OI; Mikhailov SN
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(9):510-28. PubMed ID: 24079274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
    Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
    Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.